Lethal synthesis: Difference between revisions
CSV import |
CSV import |
||
| Line 38: | Line 38: | ||
{{biochem-stub}} | {{biochem-stub}} | ||
{{No image}} | |||
Revision as of 23:30, 10 February 2025
Lethal synthesis is a biochemical phenomenon where the incorporation of a toxic or non-functional analogue of a metabolite into a biological system leads to the disruption of essential metabolic pathways, ultimately resulting in the death of the organism. This process is often exploited in the development of antibiotics and chemotherapeutic agents.
Mechanism
Lethal synthesis occurs when a cell mistakenly incorporates a structural analogue of a vital metabolite into its metabolic processes. These analogues can interfere with normal enzyme function, DNA replication, or protein synthesis, leading to cell death. The analogues are often similar enough to the natural metabolites to be taken up by the cell but different enough to disrupt normal cellular functions.
Applications
Lethal synthesis is a critical concept in the development of pharmaceuticals, particularly in the design of antibiotics and anticancer drugs. By understanding the specific metabolic pathways of pathogens or cancer cells, researchers can design analogues that selectively target these cells, minimizing damage to healthy cells.
Antibiotics
Many antibiotics function through lethal synthesis by mimicking essential bacterial metabolites. For example, sulfonamides are structural analogues of para-aminobenzoic acid (PABA), a precursor in the bacterial synthesis of folic acid. By inhibiting the enzyme that converts PABA to folic acid, sulfonamides effectively starve the bacteria of this essential nutrient, leading to their death.
Chemotherapeutic Agents
In cancer treatment, lethal synthesis is used to target rapidly dividing cells. Antimetabolites such as methotrexate and 5-fluorouracil are designed to interfere with nucleotide synthesis, thereby inhibiting DNA replication and cell division in cancer cells.
Examples
- Sulfonamides: Mimic PABA, inhibiting folic acid synthesis in bacteria.
- Methotrexate: Inhibits dihydrofolate reductase, blocking nucleotide synthesis in cancer cells.
- 5-Fluorouracil: Mimics uracil, disrupting RNA and DNA synthesis in cancer cells.
Related Concepts
See Also

This article is a biochemistry stub. You can help WikiMD by expanding it!